Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6 HKD | -0.50% | -2.45% | -10.63% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- Other languages